ABOUT RESEARCH
CONTENTS

In order to enhance the inherent self-regenerative potential of the human body and to restore tissues and organs injury, we are developing new biological materials that are non-invasive and gentle on the body. For this purpose, the technology we are promoting is called “decellularization”. This technology efficiently generates native organ derived extracellular matrix containing a large amount of collagen as well as bio-active molecules that are effective for tissue regeneration.

ABOUT MATRISURGE

Profile / Staff

Based on the research results of Keio University School of Medicine, Tokyo Metropolitan Advanced Medical Device Acceleration Project “AMDAP”
With support from JSR / Keio University Medical and Chemical Innovation Center `` JKiC ''
Established as a university venture.

Company Profile

Challenge to advanced medicine. In the unknown field of regenerative medicine, we will develop a completely different method.

INFORMATION

• 2020.06.10 Conference: Venture Council from Keio University school of Medicine MORE READ
• 2020.06.08 Conference: Progress Report in the 5th report meeting of the Advanced Medical Devices Acceleration Project MORE READ
• 2020.05.19 Performance : Chairperson in the 19th Congress of the Japanese Society for Regenerative Medicine MORE READ